In recent years, treatment guidelines for type 2 diabetes mellitus (T2DM) have been continuously updated worldwide. One of the most notable changes is the significant rise in the role of glucagon-like peptide-1 receptor agonists (GLP-1 RAs).
In the past, the primary goal of diabetes treatment w...